ArticleViruses2024
Posterior Positivity Distribution Analysis of Subclinical Bluetongue in the Eastern and North-Eastern States of India: A Wakeup Call for Outbreak Preparedness.
Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence of Bluetongue and the distribution ofFrontiers in veterinary science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bluetongue (BT) is considered endemic in the southern states of India, with sporadic incidences reported from the northern, western and central parts of India. However, the eastern and north-eastern states of India have not experienced active disease so far. In the recent past, an extensive sero-epidemiological investigation was carried out in the eastern and north-eastern Indian states. With the aim of getting updated and refined estimates of positivity rates, the sero-surveillance data were analyzed using the Markov chain Monte Carlo (MCMC) method to calculate the positivity rates of various species across different states and agro-climatic zones. The posterior positivity distribution helped in accurately estimating the seroprevalence of bluetongue virus (BTV) among different species and regions. The MCMC method was applied for the first time in a BTV seroprevalence analysis that enhanced our understanding of infection dynamics, guided targeted interventions and supported better decision-making in bluetongue disease control, prevention and disease preparedness. This exercise is quite pertinent in the context of the recent upsurge of newer BTV strains, e.g., BTV-3 and BTV-8, in the western world. In short, as a powerful computational tool, MCMC could be used for accurate seroprevalence estimation, species-specific insights, regional analysis, enhanced decision-making and epidemiological insights for bluetongue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.